Evidence map›Paper›PMID 38719292›Full record

ArticleBMJ open2024

Identifying factors that can be used to assess a country's readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: a scoping review.

Aomesh Bhatt, Vaneesha Monk, Alexandra Bhatti, Amanda L Eiden, Lindsay Hermany, Natasha Hansen, Mark P Connolly, Luke Baxter, Samantha Vanderslott, Rachel Mitrovich and 1 more

Abstract readScoping Review
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aomesh BhattDepartment of Paediatrics, University of Oxford, Oxford, UK aomesh.bhatt@paediatrics.ox.ac.uk.ORCID 0000-0001-6206-0576
Vaneesha MonkDepartment of Paediatrics, University of Oxford, Oxford, UK.ORCID 0000-0003-1578-9553
Alexandra BhattiMerck & Co Inc, Rahway, New Jersey, USA.
Amanda L EidenCenter for Observational and Real-World Evidence (CORE), Merck & Co Inc, North Wales, Pennsylvania, USA.ORCID 0000-0001-9422-1215
Lindsay HermanyMerck & Co., Inc, North Wales, Pennsylvania, USA.ORCID 0009-0008-4940-2613
Natasha HansenMerck & Co Inc, Rahway, New Jersey, USA.
Mark P ConnollyUniversity of Groningen, Groningen, The Netherlands.
Luke BaxterDepartment of Paediatrics, University of Oxford, Oxford, UK.ORCID 0000-0001-9548-7162
Samantha VanderslottDepartment of Paediatrics, University of Oxford, Oxford, UK.
Rachel Mitrovich *Merck & Co Inc, Kenilworth, New Jersey, USA.ORCID 0000-0002-3973-9369
Rebeccah Slater *Department of Paediatrics, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIdentifying whether a country is ready to deploy a new vaccine or improve uptake of an existing vaccine requires knowledge of a diverse range of interdependent, context-specific factors. This scoping review aims to identify common themes that emerge across articles, which include tools or guidance that can be used to establish whether a country is ready to deploy a new vaccine or increase uptake of an underutilised vaccine.

designScoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews guidelines. DATA SOURCES: Embase, CINAHL, Cochrane Library, Google Scholar, MEDLINE, PsycINFO and Web of Science were searched for articles published until 9 September 2023. Relevant articles were also identified through expert opinion. ELIGIBILITY CRITERIA: Articles published in any year or language that included tools or guidance to identify factors that influence a country's readiness to deploy a new or underutilised vaccine. DATA EXTRACTION AND SYNTHESIS: Two independent reviewers screened records and performed data extraction. Findings were synthesised by conducting a thematic analysis.

results38 articles met our inclusion criteria; these documents were created using methodologies including expert review panels and Delphi surveys and varied in terms of content and context-of-use. 12 common themes were identified relevant to a country's readiness to deploy a new or underutilised vaccine. These themes were as follows: (1) legal, political and professional consensus; (2) sociocultural factors and communication; (3) policy, guidelines and regulations; (4) financing; (5) vaccine characteristics and supply logistics; (6) programme planning; (7) programme monitoring and evaluation; (8) sustainable and integrated healthcare provision; (9) safety surveillance and reporting; (10) disease burden and characteristics; (11) vaccination equity and (12) human resources and training of professionals.

conclusionsThis information has the potential to form the basis of a globally applicable evidence-based vaccine readiness assessment tool that can inform policy and immunisation programme decision-makers.

Indexed as

VaccinesCOVID-19COVID-19 VaccinesHumansVaccinationCOVID-19 VaccinesVaccinesHealth EquityINFECTIOUS DISEASESPublic health

Identifiers

PMID38719292
PMCPMC11086410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.